Literature DB >> 3788845

The 1986 McCollum award lecture. Fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture.

N Freinkel, D L Cockroft, N J Lewis, L Gorman, S Akazawa, L S Phillips, G E Shambaugh.   

Abstract

Whole rat embryos were explanted at head-fold, late pre-somite stage (day 9.5 of gestation) and cultured in rat sera varyingly supplemented with glucose (3, 6, 9, or 12 mg/mL), D,L sodium beta-hydroxybutyrate (2, 4, 8, or 16 mM), or both (6 mg/mL D-glucose plus 8 mM beta-hydroxybutyrate). During 48 h culture, increasing glucose alone or beta-hydroxybutyrate alone effected growth retardation and faulty neural and extraneural organogenesis in dose-dependent fashion. Synergistic dysmorphogenic effects occurred when minimally teratogenic concentrations of glucose and beta-hydroxybutyrate were combined. Sera from diabetic animals containing somatomedin inhibitor bioactivity were also able to produce growth retardation and major developmental lesions in presence of amounts of glucose and ketones which of themselves were not teratogenic. Thus, aberrant fuels and fuel-related products can impair growth and organogenesis in early post-implantation embryo. Such fuel-mediated teratogenesis may be multifactorial and include possibilities for synergistic and additive interactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3788845     DOI: 10.1093/ajcn/44.6.986

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

1.  High glucose concentration inhibits migration of rat cranial neural crest cells in vitro.

Authors:  N Suzuki; K Svensson; U J Eriksson
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

2.  Effects of hypoglycaemia on early embryogenesis in rat embryo organ culture.

Authors:  S Akazawa; M Akazawa; M Hashimoto; Y Yamaguchi; N Kuriya; K Toyama; Y Ueda; T Nakanishi; T Mori; S Miyake
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

3.  Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos.

Authors:  L Baker; R Piddington; A Goldman; J Egler; J Moehring
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

Review 4.  Understanding diabetic teratogenesis: where are we now and where are we going?

Authors:  Sheller Zabihi; Mary R Loeken
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

5.  Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation.

Authors:  M Hashimoto; S Akazawa; M Akazawa; M Akashi; H Yamamoto; Y Maeda; Y Yamaguchi; H Yamasaki; D Tahara; T Nakanishi
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

Review 6.  Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes.

Authors:  P Catalano; S H deMouzon
Journal:  Int J Obes (Lond)       Date:  2015-01-05       Impact factor: 5.095

7.  Glucose transporter gene expression in rat conceptus during high glucose culture.

Authors:  Y Takao; S Akazawa; K Matsumoto; H Takino; M Akazawa; R A Trocino; Y Maeda; S Okuno; E Kawasaki; S Uotani
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

8.  Hyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis.

Authors:  Michelle L Baack; Chunlin Wang; Shanming Hu; Jeffrey L Segar; Andrew W Norris
Journal:  Reprod Toxicol       Date:  2014-04-08       Impact factor: 3.143

9.  Embryonic growth impaired by maternal hypoglycemia during early organogenesis in normal and diabetic rats.

Authors:  M Kawaguchi; K Tanigawa; O Tanaka; Y Kato
Journal:  Acta Diabetol       Date:  1994-09       Impact factor: 4.280

10.  Blood levels of insulin-like growth factors I and II in neonates of non-insulin-dependent diabetic rats.

Authors:  J Levy; J R Gavin
Journal:  Acta Diabetol       Date:  1994-09       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.